Propranolol Versus Placebo for Induction of Labor in Nulliparous Patients
Completed · Phase 2 · Has a placebo group
Conditions studied: Induction of Labor Affected Fetus / Newborn
In brief
A randomized, prospective trial will be offered to women admitted to the labor floors at Mount Sinai Medical Center for labor induction.
Key facts
- Study ID
- NCT03348683
- Run by
- Icahn School of Medicine at Mount Sinai
- People needed
- 240
- Starts
- 2017-12-11
- Expected to finish
- 2018-12-11
- Last updated by the study team
- 2020-01-07
Who can join
Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Nulliparous women undergoing induction of labor
- >37 weeks' gestational age
- Non-anomalous, singleton cephalic presenting fetus.
You may not qualify if…
- Multiple gestations, known fetal anomalies
- Maternal cardiac or hypertensive disease
- Chronic beta blocker use
- Bronchial asthma
- Maternal or fetal indication for immediate delivery.
Where it is running
- Icahn School of Medicine at Mount Sinai — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.